Personalis Profit Margin 2018-2024 | PSNL

Current and historical gross margin, operating margin and net profit margin for Personalis (PSNL) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Personalis net profit margin as of September 30, 2024 is -104.52%.
Personalis Annual Profit Margins
Personalis Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.270B $0.073B
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $18.693B 6.13
Dr Reddy's Laboratories (RDY) India $12.070B 23.10
BridgeBio Pharma (BBIO) United States $5.195B 0.00
Bausch Health Cos (BHC) Canada $2.824B 2.08
Amphastar Pharmaceuticals (AMPH) United States $2.031B 12.21
Supernus Pharmaceuticals (SUPN) United States $1.997B 27.20
Taysha Gene Therapies (TSHA) United States $0.424B 29.57
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.013B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00